<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR336.html">Part 336
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 336.50  Labeling of antiemetic drug products.
                            </h3>
                            <p class="depth1"><em>(a)</em> Statement of identity. The labeling of the product contains the  established name of the drug, if any, and identifies the product as an  ``antiemetic.''</p><p class="depth1"><em>(b)</em>, may also be used, as provided in Sec. 330.1(c)(2),  subject to the provisions of section 502 of the act relating to  misbranding and the prohibition in section 301(d) of the act against the  introduction or delivery for introduction into interstate commerce of  unapproved new drugs in violation of section 505(a) of the act.</p><p class="depth1"><em>(c)</em> Warnings. The labeling of the product contains the following  warnings under the heading ``Warnings:''</p><p class="depth2"><em>(1)</em> For products containing any ingredient identified in Sec.  336.10--</p><p class="depth3"><em>(i)</em> When labeled for use in adults and for those products that  can be and are labeled for use in children under 12 years of age. ``Do  not take this product, unless directed by a doctor, if you have a  breathing problem such as emphysema or chronic bronchitis, or if you  have glaucoma or difficulty in urination due to enlargement of the  prostate gland.''</p><p class="depth3"><em>(ii)</em> For those products that can be and are labeled only for  children under 12 years of age. ``Do not give this product to children  who have a breathing problem such as chronic bronchitis or who have  glaucoma, without first consulting the child's doctor.''</p><p class="depth2"><em>(2)</em> For products containing cyclizine hydrochloride identified in  Sec. 336.10(a). ``Do not give to children under 6 years of age unless  directed by a doctor.''</p><p class="depth2"><em>(3)</em> For products containing dimenhydrinate identified in Sec.  336.10(b). ``Do not give to children under 2 years of age unless  directed by a doctor.''</p><p class="depth2"><em>(4)</em> For products containing diphenhydramine hydrochloride identified  in Sec. 336.10(c). ``Do not give to children under 6 years of age  unless directed by a doctor.''</p><p class="depth2"><em>(5)</em> For products containing meclizine hydrochloride identified in  Sec. 336.10(d). ``Do not give to children under 12 years of age unless  directed by a doctor.''</p><p class="depth2"><em>(6)</em> For products containing cyclizine hydrochloride identified in  Sec. 336.10(a) or meclizine hydrochloride identified in Sec.  330.10(d). ``May cause drowsiness; alcohol, sedatives, and tranquilizers  may increase the drowsiness effect. Avoid alcoholic beverages while  taking this product. Do not take this product if you are taking  sedatives or tranquilizers, without first consulting your doctor. Use  caution when driving a motor vehicle or operating machinery.''</p><p class="depth2"><em>(7)</em> For products containing dimenhydrinate identified in Sec.  336.10(b) or diphenhydramine hydrochloride identified in Sec.  336.10(c). ``May cause marked drowsiness; alcohol, sedatives, and  tranquilizers may increase the drowsiness effect. Avoid alcoholic  beverages while taking this product. Do not take this product if you are  taking sedatives or tranquilizers, without first consulting your doctor.  Use caution when driving a motor vehicle or operating machinery.''</p><p class="depth2"><em>(8)</em> For products containing diphenhydramine hydrochloride identified  in Sec. 336.10(c). ``Do not use [bullet] \1\ with any other product  containing diphenhydramine, including one used on skin''. ---------------------------------------------------------------------------</p><p class="depth3">\1\ See Sec. 201.66(b)(4) of this chapter for definition of bullet  symbol. ---------------------------------------------------------------------------</p><p class="depth1"><em>(d)</em> Directions. The labeling of the product contains the following  information under the heading ``Directions'':</p><p class="depth2"><em>(1)</em> For products containing cyclizine hydrochloride identified in  Sec. 336.10(a). Adults and children 12 years of age and   over: Oral dosage is 50 milligrams every 4 to 6 hours, not to exceed 200  milligrams in 24 hours, or as directed by a doctor. Children 6 to under  12 years of age: Oral dosage is 25 milligrams every 6 to 8 hours, not to  exceed 75 milligrams in 24 hours, or as directed by a doctor.</p><p class="depth2"><em>(2)</em> For products containing dimenhydrinate identified in Sec.  336.10(b). Adults and children 12 years of age and over: Oral dosage is  50 to 100 milligrams every 4 to 6 hours, not to exceed 400 milligrams in  24 hours, or as directed by a doctor. Children 6 to under 12 years of  age: Oral dosage is 25 to 50 milligrams every 6 to 8 hours, not to  exceed 150 milligrams in 24 hours, or as directed by a doctor. Children  2 to under 6 years of age: Oral dosage is 12.5 to 25 milligrams every 6  to 8 hours, not to exceed 75 milligrams in 24 hours, or as directed by a  doctor.</p><p class="depth2"><em>(3)</em> For products containing diphenhydramine hydrochloride identified  in Sec. 336.10(c). Adults and children 12 years of age and over: Oral  dosage is 25 to 50 milligrams every 4 to 6 hours, not to exceed 300  milligrams in 24 hours, or as directed by a doctor. Children 6 to under  12 years of age: Oral dosage is 12.5 to 25 milligrams every 4 to 6  hours, not to exceed 150 milligrams in 24 hours, or as directed by a  doctor.</p><p class="depth2"><em>(4)</em> For products containing meclizine hydrochloride identified in  Sec. 336.10(d). Adults and children 12 years of age and over: Oral  dosage is 25 to 50 milligrams once daily, or as directed by a doctor.</p><p class="depth1"><em>(e)</em> The word ``physician'' may be substituted for the word  ``doctor'' in any of the labeling statements in this section.  [52 FR 15892, Apr. 30, 1987, as amended at 53 FR 35809, Sept. 15, 1988;  59 FR 16982, Apr. 11, 1994; 67 FR 72559, Dec. 6, 2003]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
